ABDULLAHI MUBARAK: Open Payments
NPI 1861521940 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,379 in 67 payments from 12 companies in 2025. Trend: 2023 $1,083 · 2024 $1,321 · 2025 $1,379
Food & beverage: $1,379
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $365 |
| PFIZER INC. | 6 | $214 |
| Otsuka America Pharmaceutical, Inc. | 9 | $197 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $174 |
| Almatica Pharma LLC | 5 | $119 |
| Lundbeck LLC | 3 | $70 |
| Alkermes, Inc. | 2 | $57 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Braeburn Inc. | 3 | $51 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
Products named: REXULTI, CAPLYTA, VRAYLAR, NURTEC ODT, LOREEV XR, LINZESS, ZAVZPRET, VIVITROL.
Industry payments across OH — which companies pay providers there.
